Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-02-21
2006-02-21
Chan, Christina (Department: 1644)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07002001
ABSTRACT:
Native complement pathway proteins modified such that the protein is capable of forming a down-regulation resistant C3 convertase. Preferably the modified protein is a modified human C3 protein. DNA sequences encoding such proteins are also provided, together with DNA constructs. Conjugates comprising such proteins and a specific binding moiety, for example an antibody, are also described, as are uses of such proteins and/or conjugates in therapy.
REFERENCES:
patent: 4661347 (1987-04-01), Muller-Eberhard et al.
patent: 5849297 (1998-12-01), Harrison et al.
patent: 96 07738 (1996-03-01), None
Ngo et al., (V), newly cited, in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al., (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Farries et al Xenotransplantation (1998) 5:29-34.
McNearney, TA, J. Exp. Med. (1987) 166:1525-35.
Nicol, PAE (1973) Immunol.24:259-275.
Pangburn, MK (1984) Springer Semin. Immunopathol. 7: 163-92.
Kotwal, GJ Nature (1988)335 (6186): 176-8.
Lambris et al., Biochem. J. vol. 217, pp. 323-326 (1984).
Fritzinger et al., Proc. Natl. Acad. Sci. USA, vol. 91, pp. 12775-12779 (1994).
O'Keefe et al., J. Biol. Chem., vol. 263, No. 25, pp. 12690-12697 (1988).
Hohler et al., Hum Genet. No. 96, pp. 539-541 (1995).
Lambris et al., J. Immunol. vol. 151, No. 11, pp. 6123-6134 (1993).
Ekdahl et al., J. Immunol., vol. 144, No. 11, pp. 4269-4274 (1990).
Fritzinger et al., J. Immunol., vol. 149, No. 11, pp. 3554-3562 (1992).
Daoudaki et al., J. Immunol., vol. 140, No. 5, pp. 1577-1580 (1988).
Watanabe et al., Mol. Immunol. 30, Supplement 1, p. 62 (1993).
Kew R.R. et al., J. Clin. Invest. 75: pp. 1000-1007 (1985).
Isenman D. E. et al., Biochemistry 20: pp. 4458-4467 (1981).
Fishelson Z. et al., J. Immunol. 132(3): pp. 1430-1434 (1984).
Taniguchi-Sidle A., Journal of Immunology, vol. 153, pp. 5285-5302 (1994).
Pangburn M.K., J. Immunol. vol. 142(8), pp. 2759-2765 (1989).
Fries L.F., et al., Database Biosis, pp. 1640-1655 (1984) (J. Exp. Med. vol. 160(6) Abstract only.
Becherer, J.D. & Lambris, JD, 1988, J. Biol. Chem. 263:14586-91.
Becherer, J.D., et al., 1992, Biochemistry 31:1787-94.
Ganu, VS & Muller-Eberhard, HJ, 1985, Complement 2:27.
Lambris, JD et al., 1985, Proc. Natl. Acad. Sci. USA 82:4235-9.
Lambris JD et al., 1988, J. Biol. Chem. 263:12147-50.
Esparza, I., et al., 1991, Eur. J. Immunol. 21:2829-38.
Davis, A.E., et al., 1984, J. Immunol. 132:1960-5.
Ekdahl, K.N., et al., 1990, J. Immunol. 144:4269-74.
Taniguchi-Sidle A., et al., The Journal of Biological Chemistry, vol. 267, No. 1, pp. 635-643 (1992).
Taniguchi-Sidle et al., Mol. Immunol. vol. 30, p. 54 (1993).
Fishelson Z., Molecular Immunology, vol. 28, No. 4/5, pp. 545-552 (1991).
Farries Timothy Charles
Harrison Richard Alexander
Chan Christina
Hess Susan
Imutran Limited
Vandervegt F. Pierre
LandOfFree
Down-regulation resistant C3 convertase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Down-regulation resistant C3 convertase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Down-regulation resistant C3 convertase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3710766